Author: Judie Boisvert Gutierrez, PhD, MBA – Impel Pharmaceuticals
### @@@ Nicole Gill, DO – The Ayer Neuroscience Institute Headache Center ### 2099315###Author###Physician###The Ayer Neuroscience Institute Headache Center###Author: Nicole Gill, DO – The Ayer Neuroscience Institute Headache Center
### @@@ Zubair Ahmed, MD – Cleveland Clinic ### 2099316###Author###Physician###Cleveland Clinic###Author: Zubair Ahmed, MD – Cleveland Clinic
### @@@ Robert Vann, PhD – Impel Pharmaceuticals ### 1764525###Author###Director, Medical Science Liaisons###Impel Pharmaceuticals###Author: Robert Vann, PhD – Impel Pharmaceuticals
### @@@ Sutapa Ray, PhD – Impel Pharmaceuticals ### 1764415###Author###Internal Science Liaison###Impel Pharmaceuticals###Author: Sutapa Ray, PhD – Impel Pharmaceuticals
### @@@ Sheena K. Aurora, MD – Impel Pharmaceuticals ### 2099314###Author###VP, Medical Affairs###Impel Pharmaceuticals###Author: Sheena K. Aurora, MD – Impel Pharmaceuticals
###Author: Evelyn J. Fox, MPH – Rocky Mountain Poison & Drug Safety
### @@@ Jennifer S. Jewell, DrPH – Rocky Mountain Poison & Drug Safety ### 1764476###Author###Assistant Research Scientist###Rocky Mountain Poison & Drug Safety###Author: Jennifer S. Jewell, DrPH – Rocky Mountain Poison & Drug Safety
### @@@ Joshua C Black, PhD – Rocky Mountain Poison & Drug Safety ### 1089068###Author###Senior Research Scientist###Rocky Mountain Poison & Drug Safety###Author: Joshua C Black, PhD – Rocky Mountain Poison & Drug Safety
### @@@ Matthew Ellis, PhD, MPE – Washington University School of Medicine ### 1764477###Author###Instructor in Psychiatry###Washington University School of Medicine###Author: Matthew Ellis, PhD, MPE – Washington University School of Medicine
### @@@ Heather A. Olsen, MPH – Rocky Mountain Poison & Drug Safety ### 1441301###Author###Interim Biostatistics Manager###Rocky Mountain Poison & Drug Safety###Author: Heather A. Olsen, MPH – Rocky Mountain Poison & Drug Safety
### @@@ Hannah Burkett, MS – Rocky Mountain Poison & Drug Safety ### 2099221###Author###Biostatistician I###Rocky Mountain Poison & Drug Safety###Author: Hannah Burkett, MS – Rocky Mountain Poison & Drug Safety
### @@@ Janetta Iwanicki, MD – Rocky Mountain Poison and Drug Safety ### 1764478###Author###Past Scientific Director###Rocky Mountain Poison and Drug Safety###Author: Janetta Iwanicki, MD – Rocky Mountain Poison and Drug Safety
### @@@ Sabrina H Kaplan, MD – Rocky Mountain Poison & Drug Safety ### 2099213###Author###Medical Toxicology Fellow V###Rocky Mountain Poison & Drug Safety###Author: Sabrina H Kaplan, MD – Rocky Mountain Poison & Drug Safety
### @@@ Richard C. Dart, MD, PhD – Rocky Mountain Poison & Drug Safety ### 1441206###Author###Director###Rocky Mountain Poison & Drug Safety###Author: Richard C. Dart, MD, PhD – Rocky Mountain Poison & Drug Safety
###Presenter: Kimberly L. Barefield, PharmD (she/her/hers) – PCOM School of Pharmacy
### she/her/hers PHM-10Co-Presenter: Michelle E. Brown, PharmD, BCPS – Eskenazi Health
### @@@ Andrew C. Lodolo, PharmD, BCPS, BCCCP, FCCM (he/him/his) – Eskenazi Health ### 1967863###Co-Presenter###Pharmacy Manager, Inpatient Services###Eskenazi Health###Co-Presenter: Andrew C. Lodolo, PharmD, BCPS, BCCCP, FCCM (he/him/his) – Eskenazi Health
### he/him/his MDL-03Author: Noah L. Rosen, MD, FAHS, FAAN – Northwell Department of Neurology, Zucker School of Medicine
### @@@ Ali Mohajer, PhD – Qral Group ### 2099236###Author###Management Consultant / Biostatistician###Qral Group###Author: Ali Mohajer, PhD – Qral Group
### @@@ Lucy Abraham, MSc, CPsychol – Pfizer R&D UK Ltd ### 2099237###Author###Senior Director/Value & Evidence Team Lead, Migraine###Pfizer R&D UK Ltd###Author: Lucy Abraham, MSc, CPsychol – Pfizer R&D UK Ltd
### @@@ Joshua Brown, Pharm D, PhD – Pfizer Inc ### 2099238###Author###Director, Real World Evidence###Pfizer Inc###Author: Joshua Brown, Pharm D, PhD – Pfizer Inc
### @@@ Karin Hygge Blakeman, PhD – Pfizer AB ### 2099240###Author###Global Medical Director###Pfizer AB###Author: Karin Hygge Blakeman, PhD – Pfizer AB
### @@@ Aaron Jenkins, PhD – Pfizer R&D UK Ltd ### 2099242###Author###Director, Value and Evidence###Pfizer R&D UK Ltd###Author: Aaron Jenkins, PhD – Pfizer R&D UK Ltd
### @@@ Linda A. Harris, MPH – Biohaven Pharmaceuticals ### 2099243###Author###Senior Director GHEOR###Biohaven Pharmaceuticals###Author: Linda A. Harris, MPH – Biohaven Pharmaceuticals
### @@@ Gilbert L’Italien, PhD – Biohaven Pharmaceuticals ### 2099244###Author###Head of GHEOR and Epidemiology###Biohaven Pharmaceuticals###Author: Gilbert L’Italien, PhD – Biohaven Pharmaceuticals
###Presenter: Nebojsa Nick Knezevic, MD, PhD (he/him/his) – Advocate Illinois Masonic Medical Center and University of Illinois, Chicago, IL
### he/him/his INT-02
Symposium Speaker: Charles E. Argoff, MD – Albany Medical Center
### PDM-02
Presenter: Christopher Rhyne, MD – Diamond Headache Clinic
### PDM-03Author: Srinivas Nalamachu, MD – Mid America Poly Clinic
### @@@ Elaine K. Chan, Pharm.D. – Scilex Holding Company ### 2098997###Author###Executive Director, Medical Affairs###Scilex Holding Company###Author: Elaine K. Chan, Pharm.D. – Scilex Holding Company
### @@@ Dmitri Lissin, MD – Scilex Holding Company ### 2098998###Author###Chief Medical Officer###Scilex Holding Company###Author: Dmitri Lissin, MD – Scilex Holding Company
###Author: Zoe Gonzales-Rabathaly, PA-C – Department of Interventional Pain Management, Global Neuro and Spine Institute; Department of Physical Medicine and Rehabilitation, Orlando Health Saint Cloud Hospital.
### @@@ Ali Malik, , D.O., D.A.O.P.M.R., M.S.B.E – )Department of Interventional Pain Management, Global Neuro and Spine Institute; (2) Department of Physical Medicine and Rehabilitation, Larkin Community Hospital; (3) Department of Physical Medicine and Rehabilitation, Icahn School of Medicine at Mount Sinai; ### 2099328###Author###Interventional Pain Management Physician###)Department of Interventional Pain Management, Global Neuro and Spine Institute; (2) Department of Physical Medicine and Rehabilitation, Larkin Community Hospital; (3) Department of Physical Medicine and Rehabilitation, Icahn School of Medicine at Mount Sinai;###Author: Ali Malik, , D.O., D.A.O.P.M.R., M.S.B.E – )Department of Interventional Pain Management, Global Neuro and Spine Institute; (2) Department of Physical Medicine and Rehabilitation, Larkin Community Hospital; (3) Department of Physical Medicine and Rehabilitation, Icahn School of Medicine at Mount Sinai;
### @@@ Michael Slobasky, D.O. – Department of Interventional Pain Management, Global Neuro and Spine Institute ### 2099331###Author###Medical Director###Department of Interventional Pain Management, Global Neuro and Spine Institute###Author: Michael Slobasky, D.O. – Department of Interventional Pain Management, Global Neuro and Spine Institute
###Presenter: David Cosio, PhD, ABPP (he/him/his) – Jesse Brown VA Medical Center
### he/him/his BHV-08